Discontinued — last reported Q3 '21
Business Segments · Revenue
Pharmaceutical Distribution Services — Revenue
Cencora Pharmaceutical Distribution Services — Revenue increased by 3.9% to $51.25B in Q3 2021 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2021
Rolls up toTotal Revenue
How to read this metric
Higher revenue indicates strong market demand, effective pricing, or successful expansion of the customer base.
Detailed definition
The total gross sales generated by the pharmaceutical distribution segment from the sale of branded, generic, and specia...
Peer comparison
Directly comparable to the distribution revenue of other major pharmaceutical wholesalers.
Metric ID:
cor_segment_pharmaceutical_distribution_services_revenueHistorical Data
2 periods
| Q2 '21 | Q3 '21 | |
|---|---|---|
| Value | $49.31B | $51.25B |
| QoQ Change | — | +3.9% |
Range$49.31B – $51.25B
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cencora's pharmaceutical distribution services — revenue?
- Cencora (COR) reported pharmaceutical distribution services — revenue of $51.25B in Q3 2021.
- What does pharmaceutical distribution services — revenue mean?
- Total sales revenue generated by the pharmaceutical distribution business.